Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

NCT00563017 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Schizophrenia, Catatonic
Schizophrenia, Disorganized
Schizophrenia, Paranoid
Schizophrenia
Psychotic Disorders

Interventions

DRUG: Long-acting Risperidone microspheres injection

Sponsor

Hospital Authority, Hong Kong

Collaborators

[object Object]